Equitable Holdings Inc. Has $8.97 Million Holdings in Lam Research Corporation $LRCX

Equitable Holdings Inc. raised its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 10.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,704 shares of the semiconductor company’s stock after purchasing an additional 2,003 shares during the period. Equitable Holdings Inc.’s holdings in Lam Research were worth $8,972,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in Lam Research in the fourth quarter worth approximately $3,645,427,000. Price T Rowe Associates Inc. MD lifted its stake in Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after acquiring an additional 10,666,540 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in Lam Research in the second quarter worth approximately $3,777,585,000. Franklin Resources Inc. grew its position in Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after acquiring an additional 3,671,073 shares in the last quarter. Finally, Corient Private Wealth LLC increased its stake in shares of Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock worth $890,040,000 after purchasing an additional 3,649,553 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Trading Up 1.8%

Shares of NASDAQ:LRCX opened at $318.58 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The stock’s 50-day moving average is $332.17 and its 200-day moving average is $289.05. The company has a market cap of $398.65 billion, a P/E ratio of 55.31, a P/E/G ratio of 1.24 and a beta of 1.84. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm’s revenue was up 30.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts predict that Lam Research Corporation will post 9.32 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a $0.33 dividend. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research’s dividend payout ratio (DPR) is currently 18.06%.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research raised its quarterly dividend by 27%, from $0.26 to $0.33 per share. The payment is scheduled for October 14, 2026, to shareholders of record on September 23. The increase signals confidence in cash generation and enhances shareholder returns, although future payments remain subject to board approval. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
  • Positive Sentiment: The company broke ground on a 120,000-square-foot Oregon research laboratory as part of a more than $3 billion, five-year expansion of its global lab network. The investment is intended to accelerate equipment and process innovations for advanced AI chips and deepen collaboration with major customers, supporting Lam’s long-term AI-driven growth outlook. Lam Research Breaks Ground on New Oregon Lab
  • Positive Sentiment: Recent operating momentum remains supportive: Lam’s latest reported quarter exceeded earnings and revenue expectations, with revenue up 30% year over year. Its exposure to AI-related chip manufacturing, recurring services revenue and strong balance sheet were also cited as reasons it may be preferable to some other chip stocks. Lam Research vs. Microchip
  • Neutral Sentiment: Directors Michael R. Cannon and Sohail U. Ahmed are retiring from Lam Research’s board. The planned governance transition does not appear to change the company’s near-term business outlook, but investors may monitor board succession and strategic continuity. Lam Research Announces Director Retirements
  • Neutral Sentiment: Chief Financial Officer Doug Bettinger is scheduled to participate in upcoming investor conferences, potentially providing additional commentary on semiconductor demand, AI spending and company guidance. Lam Research Announces Participation at Upcoming Conferences
  • Negative Sentiment: Mizuho lowered its price target for Lam Research to $365, a potentially cautionary signal regarding valuation or near-term semiconductor-equipment conditions. The revised target remains above the price level described in the market background, limiting the severity of the negative read-through. Mizuho Lowers Lam Research Price Target

Insider Transactions at Lam Research

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the sale, the senior vice president owned 58,470 shares in the company, valued at $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 80,441 shares of company stock worth $27,614,296. Insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on LRCX. Barclays restated an “overweight” rating and set a $335.00 price target (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. Raymond James Financial set a $425.00 target price on shares of Lam Research in a research report on Wednesday, June 10th. Jefferies Financial Group set a $335.00 target price on Lam Research and gave the company a “buy” rating in a report on Thursday, July 30th. UBS Group reaffirmed a “buy” rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. Finally, Oppenheimer reissued an “outperform” rating and set a $400.00 price objective (up from $330.00) on shares of Lam Research in a report on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and a consensus target price of $357.31.

View Our Latest Research Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.